TauRx at AAIC 2023

As sponsors of the Alzheimer’s Association International Conference® (AAIC®) in Amsterdam 16 – 20 July, together with joint venture company GT Diagnostics, we will be presenting our latest research in neurodegenerative conditions.

AAIC is the largest annual medical meeting dedicated to advancing dementia science, bringing together leaders in the space to share the latest research.

To learn more about neurofilaments and tau, please click on the links below:

Follow along on LinkedIn and Twitter for more information from AAIC 2023.

Industry News

More news

30 July 2024

MHRA confirms acceptance of UK Marketing Authorisation Application for HMTM

1 July 2024

TauRx submits UK marketing authorisation application for HMTM as a treatment for Alzheimer’s disease

Doctor examining MRI, MRT, CT scan image of human brain. Medical treatment concept. Diagnosis of the disease humans head. Close up.

7 March 2024

Two year sustained cognitive benefits of Hydromethylthionine Mesylate (HMTM) indicated by TauRx’s LUCIDITY trial

TauRx at AAIC 2023

As sponsors of the Alzheimer’s Association International Conference® (AAIC®) in Amsterdam 16 – 20 July, together with joint venture company GT Diagnostics, we will be presenting our latest research in neurodegenerative conditions.

More news

Further reading